| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2017-02-06 | ATIR101™ (Allodepleted T-cell ImmunotheRapeutics) | blood cancer patients for whom a matched donor is not available for a standard transplantation procedure | 2 | Kiadis Pharma (The Netherlands) | Cancer - Oncology |
| 2017-02-03 | ENT-01 (kenterin) | constipation associated with Parkinson's Disease | 1-2 | Enterin (USA - PA) | Neurodegenerative diseases |
| 2017-02-03 | CC100 | amyotrophic lateral sclerosis (ALS) | 1 | Chemigen (USA - IN) | Neurodegenerative diseases |
| 2017-02-03 | Viaskin® Milk | milk-induced eosinophilic esophagitis | 2a | DBV Technologies (France) | Allergic diseases - Inflammatory diseases |
| 2017-02-03 | pamrevlumab (FG-3019) | pancreatic ductal adenocarcinoma | 1-2 | FibroGen (USA - CA) | Cancer - Oncology |
| 2017-02-03 | AM-125 (betahistine dihydrochloride) | Meniere's disease, vestibular vertigo | Auris Medical (Switzerland) | Otorhinolaryngology | |
| 2017-02-02 | TG01 | resected pancreatic cancer | 1-2 | Targovax (Norway) | Cancer - Oncology |
| 2017-02-02 | Makena® (hydroxyprogesterone caproate injection) subcutaneous auto-injector program (Makena SQ) | 3 | Amag Pharmaceuticals (USA - MA) | Women health | |
| 2017-02-02 | fitusiran (SAR439774 - ALN-AT3) | hemophilia A, hemophilia B | 1 | Alnylam Pharmaceuticals (USA - MA) | Hematologic diseases - Genetic diseases - Rare diseases |
| 2017-02-02 | ABX464 | HIV infection | 1 | Abivax (France) | Infectious diseases |
| 2017-02-01 | marzeptacog alfa | hemophilia A | preclinical | Catalyst Biosciences (USA - CA) | Rare diseases - Genetic diseases - Hematological diseases |
| 2017-02-01 | Polyvac® Peanut | peanut allergy | preclinical | Allergy Therapeutics (UK) | Allergic diseases |
| 2017-02-01 | UV-4B | dengue fever | 1b | Emergent BioSolutions (USA - MD) | Infectious diseases |
| 2017-02-01 | pembrolizumab and Lanreotide Depot | gastroenteropancreatic neuroendocrine tumors | 1-2 | Duke University (USA - NC) Merck&Co (USA - NJ) Ipsen (France) | Cancer - Oncology |
| 2017-02-01 | GLPG2222 | cystic fibrosis | 2 | Galapagos (Belgium) | Rare diseases - Genetic diseases |
| 2017-01-31 | XOMA 358 | congenital hyperinsulinism | 2 | Xoma (USA - CA) | Rare diseases - Hormonal diseases - Endocrine diseases - Genetic diseases |
| 2017-01-31 | XOMA 358 | patients who experience hypoglycemia after undergoing gastric bypass surgery | 2 | Xoma (USA - CA) | Metabolic diseases |
| 2017-01-31 | Cx611 | severe sepsis in community-acquired pneumonia (CAP) | 1b/2a | TiGenix (Belgium) | Infectious diseases |
| 2017-01-26 | IMGN853 - mirvetuximab soravtansine | epithelial ovarian cancer, primary peritoneal carcinoma, Fallopian tube cancer | 3 | immunogen (USA - MA) | Cancer - Oncology |
| 2017-01-26 | BM32 | grass pollen allergy | 2 | Biomay (Austria) | Allergic diseases |
